Detalhe da pesquisa
1.
Dual CTLA-4 and PD-1 checkpoint blockade using CS1002 and CS1003 (nofazinlimab) in patients with advanced solid tumors: A first-in-human, dose-escalation, and dose-expansion study.
Cancer
; 130(11): 1991-2002, 2024 Jun 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38404184
2.
A first-in-human phase 1 study of nofazinlimab, an anti-PD-1 antibody, in advanced solid tumors and in combination with regorafenib in metastatic colorectal cancer.
Br J Cancer
; 129(10): 1608-1618, 2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37731023
3.
Effects of a prescribed, supervised exercise programme on tumour disease progression in oncology patients undergoing anti-cancer therapy: a retrospective observational cohort study.
Intern Med J
; 53(1): 104-111, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33347696
4.
Circulating tumor DNA dynamics and recurrence risk in patients undergoing curative intent resection of colorectal cancer liver metastases: A prospective cohort study.
PLoS Med
; 18(5): e1003620, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33939694
5.
A phase 1, first-in-human study of AMG 900, an orally administered pan-Aurora kinase inhibitor, in adult patients with advanced solid tumors.
Invest New Drugs
; 36(6): 1060-1071, 2018 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-29980894
6.
Phase I, pharmacokinetic and pharmacodynamic evaluation of CYT997, an orally-bioavailable cytotoxic and vascular-disrupting agent.
Invest New Drugs
; 31(1): 126-35, 2013 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-22451157
7.
Phase 1b dose-finding study of motesanib with docetaxel or paclitaxel in patients with metastatic breast cancer.
Breast Cancer Res Treat
; 135(1): 241-52, 2012 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-22872523
8.
Safety and pharmacokinetics of motesanib in combination with gemcitabine and erlotinib for the treatment of solid tumors: a phase 1b study.
BMC Cancer
; 11: 313, 2011 Jul 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-21791058
9.
Anti-cytotoxic T-lymphocyte-associated antigen-4 monoclonal antibody quavonlimab in combination with pembrolizumab: Safety and efficacy from a phase I study in previously treated extensive-stage small cell lung cancer.
Lung Cancer
; 159: 162-170, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34371366
10.
Epidemiology of neuroendocrine cancers in an Australian population.
Cancer Causes Control
; 21(6): 931-8, 2010 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-20419344
11.
Malignant pleural mesothelioma with associated minimal change disease and acute renal failure.
Ren Fail
; 32(8): 1012-5, 2010.
Artigo
em Inglês
| MEDLINE | ID: mdl-20722572
12.
Quality of Surgery and Outcome in Localized Gastrointestinal Stromal Tumors Treated Within an International Intergroup Randomized Clinical Trial of Adjuvant Imatinib.
JAMA Surg
; 155(6): e200397, 2020 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32236507
13.
Response to erlotinib in a patient with treatment refractory chordoma.
Anticancer Drugs
; 20(10): 953-5, 2009 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-19730087
14.
Exploring the epidemiological characteristics of cancers of unknown primary site in an Australian population: implications for research and clinical care.
Aust N Z J Public Health
; 32(4): 383-9, 2008 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-18782405
15.
Phase IB Trial of the Anti-Cancer Stem Cell DLL4-Binding Agent Demcizumab with Pemetrexed and Carboplatin as First-Line Treatment of Metastatic Non-Squamous NSCLC.
Target Oncol
; 13(1): 89-98, 2018 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-29188408
16.
Imatinib does not induce cardiac left ventricular failure in gastrointestinal stromal tumours patients: analysis of EORTC-ISG-AGITG study 62005.
Eur J Cancer
; 43(6): 974-8, 2007 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-17336514
17.
Ten-Year Progression-Free and Overall Survival in Patients With Unresectable or Metastatic GI Stromal Tumors: Long-Term Analysis of the European Organisation for Research and Treatment of Cancer, Italian Sarcoma Group, and Australasian Gastrointestinal Trials Group Intergroup Phase III Randomized Trial on Imatinib at Two Dose Levels.
J Clin Oncol
; 35(15): 1713-1720, 2017 May 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-28362562
18.
Darbepoetin alfa for the treatment of chemotherapy-induced anemia: disease progression and survival analysis from four randomized, double-blind, placebo-controlled trials.
J Clin Oncol
; 23(28): 6941-8, 2005 Oct 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-16192582
19.
Primary pericardial mesothelioma presenting as multiple pericardial masses on CT.
BJR Case Rep
; 2(1): 20150295, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-30364446
20.
Motesanib with or without panitumumab plus FOLFIRI or FOLFOX for the treatment of metastatic colorectal cancer.
Cancer Chemother Pharmacol
; 75(5): 993-1004, 2015 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-25772756